ReNAgade Therapeutics

About:

ReNAgade Therapeutics focuses on the boundless potential of RNA therapeutics to treat disease.

Twitter/X: ReNAgadeTx

Top Investors: MPM Capital, F2 Ventures

Description:

ReNAgade Therapeutics focuses on the boundless potential of RNA therapeutics to treat disease. RNA delivery systems with a comprehensive RNA platform that allows for an all-RNA system for coding, editing, and gene insertion to produce new medications.

Total Funding Amount:

$300M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2021-01-01

Contact Email:

info(AT)renagadetx.com

Founders:

Brian Goodman

Number of Employees:

101-250